Regeneron Pharmaceuticals Analysts Recommendations and Consensus

REGN -- USA Stock  

USD 368.78  2.06  0.56%

The current analyst and expert consensus on Regeneron Pharmaceuticals is Hold with 10 hold recommendations. The current projected target price consensus is 428.29 with 14 analysts opinions. One of the most common ways Regeneron Pharmaceuticals analysists use to provide buy or sell recommendation to public are conference calls analysis and financial statements evaluations. Some experts can also talk to Regeneron Pharmaceuticals vendors, executives, and/or customers. Regeneron Pharmaceuticals recommendation module provides expert sentiment on the projected Regeneron Pharmaceuticals target price to derive its highest and lowest estimates based on target price standard deviation of 65.584. Additionally take a look at Macroaxis Advice on Regeneron Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

Regeneron Pharmaceuticals Target Price Consensus

Number of Opinions18
Lowered Outlook0
Raized Outlook0
Hold
Macroaxis Recommendation   Exposure   Valuation

Regeneron Pharmaceuticals Target Price Projection

Current Price

Regeneron Pharmaceuticals Market Quote
Low Price364.86Odds
High Price371.85Odds

368.78

Target Price

Analyst Consensus On Target Price
Low Estimate345.0Odds
High Estimate598.0Odds
Number of Analysts14
Standard Deviation65.584

428.285

Regeneron Pharmaceuticals Analysit Ratings

Average Consensus

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Current Thematic Trending

Impulse
Purchased over 500 shares
Traded few days ago for 6.08
Impulse
Purchased over 500 shares
Traded few days ago for 6.08
Advertising
Purchased over 100 shares
Traded few days ago for 2.17
Baby Boomer Prospects
Purchased over 40 shares
Traded few days ago for 71.99
Driverless Cars
Purchased over 300 shares
Traded few days ago for 9.91
Driverless Cars
Purchased over 70 shares
Traded few days ago for 37.5
Additionally take a look at Macroaxis Advice on Regeneron Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon. Please also try Portfolio Reporting module to create custom reports across your portfolios and generate quick suggestion pitch.